Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-12 · accession 0000950170-24-073704 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-12 | NTLA | Verwiel Frank | Dir | A - Grant | $0.00 | +7,737 | 19.5K | +66% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | Verwiel Frank | Dir | A - Grant | $0.00 | +11.5K | 11.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-12 | A | A | 7,737 | $0.00 | 19,453 | D | — | — | (F1) Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-12 | A | A | 11,515 | $0.00 | 11,515 | D | $25.85 · — to 2034-06-11 | 11,515 Common Stock | (F2) This option was granted on June 12, 2024 with respect to 11,515 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. |